- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 Drug Discovery Using Intensive Approaches
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 8, Pages 2839
Publisher
MDPI AG
Online
2020-04-21
DOI
10.3390/ijms21082839
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Compounds with therapeutic potential against novel respiratory 2019 coronavirus
- (2020) Miguel Angel Martinez ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient
- (2020) Sean Wei Xiang Ong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
- (2020) Calvin J Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Understanding of COVID‐19 based on current evidence
- (2020) Pengfei Sun et al. JOURNAL OF MEDICAL VIROLOGY
- Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
- (2020) Kimiyasu Shiraki et al. PHARMACOLOGY & THERAPEUTICS
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
- (2020) Xintian Xu et al. Science China-Life Sciences
- Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection
- (2020) Enya Qing et al. mBio
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Detection of SARS-CoV-2 in Different Types of Clinical Specimens
- (2020) Wenling Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
- (2020) Lisi Deng et al. JOURNAL OF INFECTION
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Disruption of Endolysosomal RAB5/7 Efficiently Eliminates Colorectal Cancer Stem Cells
- (2019) Mitsunobu Takeda et al. CANCER RESEARCH
- Broad receptor engagement of an emerging global coronavirus may potentiate its diverse cross-species transmissibility
- (2018) Wentao Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- Poly(ethylene glycol)–poly(lysine) block copolymer–ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells
- (2018) Reishi Toshiyama et al. ONCOGENE
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
- (2017) Timothy P. Sheahan et al. Science Translational Medicine
- GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo- and Paramyxoviruses
- (2017) Michael K. Lo et al. Scientific Reports
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- Molecular mechanisms of coronavirus RNA capping and methylation
- (2016) Yu Chen et al. VIROLOGICA SINICA
- Autophagy inhibitors
- (2015) Benoit Pasquier CELLULAR AND MOLECULAR LIFE SCIENCES
- Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors
- (2014) Raphael N. Vuille-dit-Bille et al. AMINO ACIDS
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Structural basis for viral 5′-PPP-RNA recognition by human IFIT proteins
- (2013) Yazan M. Abbas et al. NATURE
- Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model
- (2012) Yiwu Yan et al. CELL RESEARCH
- Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5
- (2011) Roland Züst et al. NATURE IMMUNOLOGY
- A brilliant disguise for self RNA: 5’-end and internal modifications of primary transcripts suppress elements of innate immunity
- (2011) Subba Rao Nallagatla et al. RNA Biology
- RIG-I Detects Viral Genomic RNA during Negative-Strand RNA Virus Infection
- (2010) Jan Rehwinkel et al. CELL
- Lucanthone Is a Novel Inhibitor of Autophagy That Induces Cathepsin D-mediated Apoptosis
- (2010) Jennifer S. Carew et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD13 is a therapeutic target in human liver cancer stem cells
- (2010) Naotsugu Haraguchi et al. JOURNAL OF CLINICAL INVESTIGATION
- 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members
- (2010) Stephane Daffis et al. NATURE
- Regulation of mRNA cap methylation
- (2009) Victoria H. Cowling BIOCHEMICAL JOURNAL
- Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion
- (2008) Y. Boriskin et al. CURRENT MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More